2020
DOI: 10.1016/j.jcin.2020.03.052
|View full text |Cite
|
Sign up to set email alerts
|

Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
52
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(52 citation statements)
references
References 74 publications
0
52
0
Order By: Relevance
“…In patients undergoing SAVR, degenerative severe MR, preserved LV function, presence of atrial fibrillation, and/or pulmonary hypertension also might be important determinants for concomitant mitral surgery. 26 The current study results might have implications for the indications of mitral valve surgery at time of SAVR in patients with severe AS and concomitant MR. This subgroup analysis included a small number of patients, and thus we could not make adjusted comparison between those with and without MV surgery.…”
Section: Discussionmentioning
confidence: 75%
“…In patients undergoing SAVR, degenerative severe MR, preserved LV function, presence of atrial fibrillation, and/or pulmonary hypertension also might be important determinants for concomitant mitral surgery. 26 The current study results might have implications for the indications of mitral valve surgery at time of SAVR in patients with severe AS and concomitant MR. This subgroup analysis included a small number of patients, and thus we could not make adjusted comparison between those with and without MV surgery.…”
Section: Discussionmentioning
confidence: 75%
“…During the follow-up post-TAVI, new-onset of MR was reported in discharge diagnosis in 1632 patients (4.2%), meanwhile, 416 patients (0.91%) had new onset of TR. During the follow-up, the yearly incident all-cause mortality rate was 16 S2) Likewise, the S2) Likewise, the yearly incidence and risks of cardiovascular mortality and rehospitalization for heart failure were significantly higher in TAVI patients with MR than those without. No difference was observed in the incidence and risk of stroke between the two groups (Table S2).…”
Section: Resultsmentioning
confidence: 95%
“…Although no significant impact of MR on post-TAVI survival was reported in smaller cohorts [11,12], a meta-analysis demonstrated that significant MR was associated with increased 30-day (pooled odds ratio OR: 1.49, 95% confidence interval CI: 1.16-1.92) and 1-year mortality (pooled hazard ratio HR: 1.32, 95%CI: 1.12-1.55) [13]. Concomitant tricuspid regurgitation (TR), however, is less prevalent than MR in TAVI population, and majority of significant TR are secondary to pulmonary hypertension and right ventricle remodeling [12,[14][15][16]. Baseline moderate to severe TR and right ventricular dysfunction are associated with increased all-cause mortality post TAVI [17].…”
Section: Introductionmentioning
confidence: 99%
“…Transcatheter mitral valve replacement or repair (TMVR/r) at a later date may be an option for these patients, but the outcome is likely to be suboptimal if the valve cannot be surgically repaired [ 67 ]. When a patient’s surgical risk is high or prohibitive, a staged procedure with TAVR, possibly followed by TMVR/r for patients whose MR did not regress, appears appealing [ 68 ]. However, the persistence of severe MR requires cautious clinical reassessment.…”
Section: Decision-making and The Role Of Heart Teammentioning
confidence: 99%